API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
94
PharmaCompass offers a list of Cloperastine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cloperastine manufacturer or Cloperastine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cloperastine manufacturer or Cloperastine supplier.
PharmaCompass also assists you with knowing the Cloperastine API Price utilized in the formulation of products. Cloperastine API Price is not always fixed or binding as the Cloperastine Price is obtained through a variety of data sources. The Cloperastine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cloperastine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cloperastine, including repackagers and relabelers. The FDA regulates Cloperastine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cloperastine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cloperastine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cloperastine supplier is an individual or a company that provides Cloperastine active pharmaceutical ingredient (API) or Cloperastine finished formulations upon request. The Cloperastine suppliers may include Cloperastine API manufacturers, exporters, distributors and traders.
click here to find a list of Cloperastine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cloperastine Drug Master File in Japan (Cloperastine JDMF) empowers Cloperastine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cloperastine JDMF during the approval evaluation for pharmaceutical products. At the time of Cloperastine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cloperastine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cloperastine Drug Master File in Korea (Cloperastine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cloperastine. The MFDS reviews the Cloperastine KDMF as part of the drug registration process and uses the information provided in the Cloperastine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cloperastine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cloperastine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cloperastine suppliers with KDMF on PharmaCompass.
Cloperastine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cloperastine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cloperastine GMP manufacturer or Cloperastine GMP API supplier for your needs.
A Cloperastine CoA (Certificate of Analysis) is a formal document that attests to Cloperastine's compliance with Cloperastine specifications and serves as a tool for batch-level quality control.
Cloperastine CoA mostly includes findings from lab analyses of a specific batch. For each Cloperastine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cloperastine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cloperastine EP), Cloperastine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cloperastine USP).